tocophersolan has been researched along with naringenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunukula, A; Kulhari, H; Pooja, D; Ravuri, HG; Singh, MK; Sistla, R | 1 |
| Radhakrishnan, A; Rajamani, S; Sengodan, T; Thangavelu, S | 1 |
2 other study(ies) available for tocophersolan and naringenin
| Article | Year |
|---|---|
Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Drug Delivery Systems; Drug Stability; Flavanones; Male; Nanoparticles; Nanostructures; Particle Size; Polyethylene Glycols; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Suspensions; Vitamin E | 2018 |
Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Survival; Drug Resistance, Neoplasm; Flavanones; Humans; Liver; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Reactive Oxygen Species; Suspensions; Vitamin E | 2018 |